Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid
暂无分享,去创建一个
[1] P. Golusiński,et al. Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma , 2014, Postepy dermatologii i alergologii.
[2] M. Péč,et al. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. , 2011, Acta Dermatovenerologica Alpina Pannonica et Adriatica.
[3] R. Vieira,et al. Incidence and factors associated with recurrence after incomplete excision of basal cell carcinomas: a study of 90 cases , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] A. Crowson. Biopsy Interpretation of the Skin , 2010 .
[5] G. Muțiu,et al. Eyelid tumors: histopathological and clinical study performed in County Hospital of Oradea between 2000-2007. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[6] P. Birembaut,et al. Aneuploidy, but not Ki‐67 or EGFR expression, is associated with recurrences in basal cell carcinoma , 2008, Journal of cutaneous pathology.
[7] P. Walker,et al. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment , 2006, The Australasian journal of dermatology.
[8] P. Leboit,et al. Pathology and genetics of skin tumours , 2006 .
[9] C. Shields,et al. Sebaceous carcinoma of the ocular region: a review. , 2005, Survey of ophthalmology.
[10] G. Renard,et al. Basal Cell Carcinomas of the Eyelids , 2005, Ophthalmologica.
[11] A. Nasierowska-Guttmejer. „Patologia znaczy słowo o chorobie" (Jerzy Stachura, Wenancjusz Domagała) , 2005 .
[12] C. Sotozono,et al. Ki-67 Labeling Index as a Marker of Malignancy in Ocular Surface Neoplasms , 2004, Japanese Journal of Ophthalmology.
[13] J. Bonnetblanc,et al. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions , 2004, The British journal of dermatology.
[14] M. Sułkowska,et al. An evaluation of Ki-67 and PCNA expression in conjunctival and eyelid tumours. , 2004, Folia Morphologica.
[15] R. Dummer,et al. Superficial radiotherapy for patients with basal cell carcinoma , 2003, Cancer.
[16] Harjinder S. Dhaliwal,et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma. , 2002, Ophthalmology.
[17] M. Maloney,et al. The significance of tumor persistence after incomplete excision of basal cell carcinoma. , 2002, Journal of the American Academy of Dermatology.
[18] G. Bartley,et al. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. , 2001, Ophthalmology.
[19] K. Nouri,et al. Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication? , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[20] A. Kopf,et al. Recurrence rates of treated basal cell carcinomas. , 1993, The Journal of dermatologic surgery and oncology.
[21] C. Grin,et al. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. , 1991, The Journal of dermatologic surgery and oncology.
[22] D. Jones,et al. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. , 1990, Journal of the American Academy of Dermatology.
[23] W. Green,et al. Squamous cell carcinoma of the eyelids. , 1987, Ophthalmology.